Libya vs Lithuania: Access to anti-retroviral drugs, male
Libya
49.0%
in 2023
Lithuania
50.0%
in 2024
Libya rank
119th
Lithuania rank
117th
Access to anti-retroviral drugs, male over time
- Libya
- Lithuania
How they compare
Lithuania currently reports 50.0% against 49.0% in Libya, a difference of 1.0%.
Across all 24 years both countries report, Libya has been ahead every year.
Libya ranks 119th and Lithuania ranks 117th of 141 countries.
Libya has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Libya | Lithuania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 29.0% | 3.5% | 25.5% | Libya |
| 2010s | 63.9% | 21.8% | 42.1% | Libya |
| 2020s | 47.8% | 41.8% | 6.0% | Libya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Libya or Lithuania?
- Lithuania, at 50.0% against 49.0% in Libya as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Libya and Lithuania?
- 1.0%, with Lithuania ahead.
- How many years of comparable data are there for Libya and Lithuania?
- 24 years are reported by both, from 2000 to 2023.
- How do Libya and Lithuania rank globally for access to anti-retroviral drugs, male?
- Libya ranks 119th and Lithuania ranks 117th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.